Mutations in PIK3CA and AKT1 are frequent in meningiomas, whereas activating mutations affecting the RAS/RAF/MEK/ERK, PI3K/AKT, and Wnt pathways have been described in pituitary adenomas [153,154]. Here, AKT1 is linked to pituitary gland adenoma.